Karyopharm Therapeutics nombra a Lori Macomber directora financiera
Acceder al artículo original.
Póngase en contacto con nosotros para cualquier solicitud de corrección

Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,6310 USD | -3,96 % |
|
+1,43 % | -6,70 % |
Acceder al artículo original.
Póngase en contacto con nosotros para cualquier solicitud de corrección
Lori Macomber is currently the Chief Financial Officer, Treasurer & Executive VP at Karyopharm Therapeutics, Inc. She previously worked as the Business Unit Controller at AMETEK, Inc. from 2018 to 2019, the Assistant VP-Finance Site Leader at Eli Lilly & Co. from 2010 to 2017, and the Controller & Chief Financial Officer-US Region at Cello Health Ltd.
from 2017 to 2018.
She also served as the Chief Financial Officer at Legend Biotech Corp.
from 2019 to 2025.
Ms. Macomber obtained her undergraduate degree from The Pennsylvania State University.